Has Ira Lieber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,340,535 in general payments to Ira Lieber, MD across 733 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ira Lieber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ira Lieber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ira Lieber, MD

Interventional Cardiology · Kingwood, TXNPI 1619977477

Payments from drug & device makers

$3,340,535in general payments, 2019–2025

Across 733 payments — averaging $4557.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$1.9M
Amgen$692K
Janssen Research & Development, LLC$348K
AbbVie$157K
Boehringer Ingelheim International GmbH$81K
Boehringer Ingelheim Pharma GmbH & Co.kg$59K
plus $142K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	30	$1,860,993
Amgen	43	$692,019
Janssen Research & Development, LLC	40	$347,805
AbbVie	59	$156,905
Boehringer Ingelheim International GmbH	73	$81,211
Boehringer Ingelheim Pharma GmbH & Co.kg	5	$59,366
AstraZeneca	5	$49,696
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	29	$36,541
Bayer	6	$26,441
Merck	27	$11,239
Novo Nordisk AS	151	$5,422
Abbott	56	$4,147
Boehringer Ingelheim	6	$3,164
Boston Scientific	57	$1,335
Biotronik Inc.	9	$758
Novo Nordisk	24	$510
Johnson & Johnson	24	$491
Impulse Dynamics (USA) Inc.	10	$438
Medtronic(2 entities)	9	$349
Tactile Systems Technology Inc	15	$250
Angiodynamics, Inc.	3	$173
Merz North America, Inc.	3	$160
Astellas Pharma US Inc	7	$151
E.r. Squibb & Sons, L.L.C.	7	$120
Kestra Medical Technology Services, Inc.	1	$102
Asahi Intecc USA, Inc.	1	$91
Inspire Medical Systems, Inc.	1	$72
Abiomed	2	$61
Arbor Pharmaceuticals, Inc.	3	$52
Esperion Therapeutics, Inc.	3	$52
Amarin Pharma, Inc.	3	$47
Shockwave Medical, Inc	2	$45
Sanofi-aventis U.S. LLC	2	$42
Irhythm Technologies, Inc.	2	$35
Bard Peripheral Vascular, Inc.	1	$35
Teleflex LLC	2	$29
Alnylam Pharmaceuticals Inc.	1	$26
Pfizer	2	$25
Altathera Pharmaceuticals LLC	1	$23
Penumbra, Inc.	1	$20
Inari Medical, Inc.	1	$18
Lexicon Pharmaceuticals, Inc.	1	$15
Kowa Pharmaceuticals America, Inc.	1	$15
Avinger Inc.	1	$14
ZOLL Circulation Inc	1	$13
Itamar Medical Inc	1	$12
Vivaquant Inc, Dba Rhythm Express	1	$9

How this compares

$3,340,535 in reported general payments places this provider in the 95th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas →

Medicare billing

Part B allowed, 2024

$1,581,135

Medicare patients

393

Services billed

11,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Kingwood

Robert StolerDallas$8.2M
James ChoiDallas$5.2M
Srinivasa PotluriPlano$5.1M
Neal KleimanHouston$4.8M
Juan GranadaHouston$4.3M
Cara Ann EastDallas$3M
Abhijeet DhobleHouston$2.7M
Jeffrey CarrTyler$2.7M
M Asad KarimMcKinney$2.7M
Sameh SayfoPlano$2.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →